Epstein Secrets

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

e 20 years and above: 106.0-719.0 pg/mL Analysis by High Performance Liquid Chromatography/ TandemMass Spectrometry (LC-MS/MS) (7) Performed by: National Medical Lab 2300 Stratford Ave. Willow Grove, PA 19090 eioeeference Laboratories, Inc. 481 Edward H. Ross Dr I Elmwood Park, Nl 07467 I (800) Jones Weisberg

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

L Analysis by High Performance Liquid Chromatography/ TandemMass Spectrometry (LC-M5/MS) 106-719 pg/mt. I 278.0 01/27/2616 (7) Performed by: National Medical Lab 2300 Stratford Ave. Willow Grove, PA 19090 BioReference Laborator 481 Edward H. ROSS or 1111~1 lases Weisberger, N.D. Clinical Page 5 of 6 Lab

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

/mL Analysis by High Performance Liquid Chromatography/ Tandem:lass Spectrometry (LC-MS/I45) 106-719 pg/st 278.0 01/27/2016 (7) Performed by: National Medical Lab 2300 Stratford Ave. Willow Grove, PA 19090 BioReference Laboratories, Inc. 481 Edward H. Ross Dr I Elmwood Park, NJ 07407 I (800) lames weisberge